Upcoming Healthcare Conferences Featuring Pacira BioSciences
Pacira BioSciences, Inc. (NASDAQ: PCRX) is making significant strides in the healthcare industry by offering innovative non-opioid pain management solutions. The company has announced its participation in a couple of important healthcare conferences that will give analysts and investors insights into its future direction.
Details on Conference Participation
The first event is the Jefferies London Healthcare Conference, set for an engaging session on Tuesday, November 18, at 1:30 PM GMT (8:30 AM ET). Following this, Pacira will also present at the 37th Annual Piper Sandler Healthcare Conference on Tuesday, December 2, at 1:30 PM ET. These conferences represent a pivotal moment for the company as they continue to advocate for innovative, science-based pain management alternatives.
Accessing Live Events
For those interested in listening to the live audio of these events, it can be easily accessed through the “Events” page on the company’s official website. If you miss these live sessions, do not worry! A replay will be available for two weeks after the events, making it convenient for everyone to stay updated on Pacira's developments.
Innovative Pain Management Solutions
At the heart of Pacira's mission is a commitment to transform the lives of patients suffering from pain. The company boasts a portfolio of three FDA-approved, commercial-stage non-opioid treatments. One of the flagship products is EXPAREL, a long-acting local analgesic that caters to a variety of surgical needs, including infiltration and nerve block procedures.
EXPAREL's Role in Post-Surgical Pain Management
EXPAREL has been approved for use in various settings, such as infiltration for postsurgical pain management and specific nerve block procedures. Its long-lasting properties mean that patients can experience reduced pain levels and, in many cases, lessen their reliance on traditional opioids, thus mitigating the risks associated with opioid use.
Other Notable Treatments
Beyond EXPAREL, Pacira offers ZILRETTA, which is utilized for the management of osteoarthritis knee pain. This extended-release injectable suspension helps patients manage their chronic pain more effectively without the adverse effects often associated with more traditional pain relief options.
Introduction of Ioveraº Technology
Another exciting product from Pacira is the ioveraº, a handheld device designed for immediate and sustained pain control. It uses the innovative approach of precise, controlled doses of cold temperature to target nerves effectively. This method offers patients a drug-free alternative to managing their pain, aligning with the company's focus on non-opioid therapies.
Commitment to Research and Development
As part of its ongoing commitment to innovation, Pacira is advancing its investigational product, PCRX-201 (enekinragene inzadenovec). This novel gene therapy aims to address prevalent diseases, notably osteoarthritis, which significantly impacts the quality of life for many individuals. The potential of this therapy demonstrates the company’s dedication to being at the forefront of medical advancements.
Conclusion
With their upcoming participation in significant healthcare conferences and their commitment to delivering advanced non-opioid pain relief solutions, Pacira BioSciences, Inc. is poised to make a lasting impact in the healthcare landscape. Their innovative approach and dedication to patient care position them as a leader in evolving pain management strategies.
Frequently Asked Questions
What are the key conferences Pacira is attending?
Pacira will participate in the Jefferies London Healthcare Conference and the Piper Sandler Healthcare Conference.
What are the primary products offered by Pacira?
Pacira offers EXPAREL, ZILRETTA, and the ioveraº as their leading non-opioid pain management therapies.
What is the significance of EXPAREL?
EXPAREL is a long-acting local analgesic that provides effective pain relief for various surgical procedures, reducing opioid reliance.
How can I access the live audio of the conferences?
The live audio can be accessed via the “Events” page on Pacira’s official website.
What is PCRX-201?
PCRX-201 is an investigational gene therapy aimed at treating prevalent conditions like osteoarthritis, demonstrating Pacira's commitment to innovation.
